Entering text into the input field will update the search result below

Organogenesis gains the most in over a year after strong Q4 earnings beat

Mar. 02, 2022 10:30 AM ETOrganogenesis Holdings Inc. (ORGO) StockBy: Dulan Lokuwithana, SA News Editor

Top view of calculator,pen,sand clock,plant and paper written with Shareholder on wooden background.Business and finance concept.

Mohamad Faizal Bin Ramli/iStock via Getty Images

  • Organogenesis (ORGO +22.4%) a regenerative medicine company based in Canton, Massachusetts, has recorded the biggest intra-day gain since January 2021 on Wednesday after reporting better than expected financials for Q4 2021

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

About ORGO

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
Organogenesis Holdings Inc.
AnaptysBio, Inc.
UroGen Pharma Ltd.
Aura Biosciences, Inc.
Replimune Group, Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.